| Cat. No. |
Product Name |
Information |
| PC-63452 |
RO5454291
CDK5-p25 inhibitor
|
RO5258638 is a small molecule inhibitor of CDK5-p25 protein-protein interaction with IC50 of 1.39 uM.. |
| PC-63451 |
RO5258638
CDK5-p25 inhibitor
|
RO5258638 is a small molecule inhibitor of CDK5-p25 protein-protein interaction.. |
| PC-63305 |
HSD992
CDK2/3 inhibitor
|
HSD992 is a potent, selective CDK2/3 inhibitor with moderate CDK9 inhibition with IC50 of 18 nM, 57 nM and 49 nM for CDK3/cyclin E, CDK2/cyclin A1 and CDK2/cyclin E, respecively. |
| PC-63252 |
BI-1347
CDK8/CDK19 inhibitor
|
BI-1347 is a potent, selective inhibitor of CDK8/CDK19 with IC50 of 1.4 nM/1.9 nM, respectively. |
| PC-43411 |
CDK9-IN-1
CDK9 inhibitor
|
CDK9-IN-1 is a potent, selective CDK9 inhibitor with IC50 of 39 nM (CDK9/CycT1), >10-fold selectivity over CDK4 and >100-fold over CDK1/2/3/5/6/7, inhibits HIV-1 replication in cellular assays. |
| PC-43342 |
CDK9-IN-2
CDK9 inhibitor
|
CDK9-IN-2 (CDK9 inhibitor II) is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1. |
| PC-43145 |
CCT251545
Wnt inhibitor, CDK8/19 inhibitor
|
CCT251545 is a potent, orally bioavailable inhibitor of Wnt signaling with IC50 of 5 nM, also is a potent and selective chemical probe for CDK8 and CDK19 with >100-fold selectivity over 291 other kinases. |
| PC-43121 |
ON123300
Multi-kinases inhibitor
|
Narazaciclib (ON123300) is a potent, multi-targeted kinase inhibitor with IC50 of 5, 3.9, 26, 26, 9.2 and 11 nM for ARK5, CDK4, PDGFRβ, FGFR1, RET and FYN, respectively. |
| PC-63235 |
CDK inhibitor E9
CDK9 inhibitor
|
CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12. |
| PC-63209 |
Alsteropaullone
CDK/GSK3β inhibitor
|
Alsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM. |
| PC-43098 |
Ro-3306
CDK1 inhibitor
|
Ro-3306 is a potent, selective, ATP-competitive CDK1 inhibitor with Ki of 35 nM against CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and >50-fold relative to CDK4/cyclin D. |
| PC-43037 |
CDKI-73
CDK9 inhibitor
|
Asnuciclib (CDKI-73) is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM. |
